Boothbay Fund Management’s Apyx Medical APYX Stock Holding History

Boothbay Fund Management’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-40,000	Closed	-$201K	–	1707
2023 Q2	$201K	Sell	40,000 -102,811	-72%	-$521K	﹤0.01%	1491
2023 Q1	$411K	Buy	+142,811	New	+$417K	0.01%	1341
2019 Q2	–	Sell	-10,065	Closed	-$64K	–	725
2019 Q1	$64K	Buy	+10,065	New	+$77.9K	0.01%	685

Other funds holding APYX

ACM

Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PVI

Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

Boothbay Fund Management's APYX Position: Q3 2023 in Review

Boothbay Fund Management sold out of Apyx Medical (APYX) in Q3 2023, closing a stake of 40,000 shares — an estimated $201K sold.

Boothbay Fund Management first reported a position in APYX in Q1 2019 and held it in 3 quarters. The position peaked at $411K in Q1 2023. 62 funds tracked by Wall St. Rank hold APYX as of Q3 2023.

Boothbay Fund Management reported no remaining Apyx Medical position as of Q3 2023 after selling out during the quarter.
Boothbay Fund Management sold 40,000 Apyx Medical shares in Q3 2023, an estimated $201K.
Boothbay Fund Management first reported a position in Apyx Medical in Q1 2019 and held it in 3 quarters.
Boothbay Fund Management's Apyx Medical position peaked at $411K in Q1 2023.
62 funds tracked by Wall St. Rank held Apyx Medical as of Q3 2023.

Based on Boothbay Fund Management's 13F filing for Q3 2023, filed 14 Nov 2023.